Real-World Data of the Correlation between EGFR Determination by Liquid Biopsy in Non-squamous Non-small Cell Lung Cancer (NSCLC) and the EGFR Profile in Tumor Biopsy.

Autor: Soria-Comes T; Department of Medical Oncology, Hospital Universitario Doctor Peset, 46017, Comunitat Valenciana, Valencia, Spain. t.soria.comes@gmail.com., Palomar-Abril V, Ureste MM; Department of Medical Oncology, Hospital Universitario Doctor Peset, 46017, Comunitat Valenciana, Valencia, Spain., Guerola MT; Department of Medical Oncology, Hospital Universitario Doctor Peset, Comunitat Valenciana, Valencia, Spain., Maiques ICM; Department of Medical Oncology, Hospital Universitario Doctor Peset, 46017, Comunitat Valenciana, Valencia, Spain.

Publikováno v: Pathology oncology research : POR [Pathol Oncol Res] 2020 Apr; Vol. 26 (2), pp. 845-851. Date of Electronic Publication: 2019 Mar 07.

Liquid profiling for cancer patient stratification in precision medicine – current status and challenges for successful implementation in standard care.

Autor: Haselmann, Verena, Hedtke, Maren, Neumaier, Michael

Publikováno v: Journal of Laboratory Medicine; Aug2022, Vol. 46 Issue 4, p225-236, 12p

Prediction model based on ¹⁸F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.

Autor: Hong-Yue ZHAO, Ye-Xin SU, Lin-Han ZHANG1, Peng FU

Publikováno v: Neoplasma; 2022, Vol. 69 Issue 1, p233-241, 9p

Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA TP53 Mutations-A Perspective from a Real-World Precision Medicine Cohort.

Autor: Rosenberg S; Gaffin Center for Neuro-Oncology, Sharett Institute for Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. shair@hadassah.org.il.; The Wohl Institute for Translational Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel., Okamura R; Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California., Kato S; Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California., Soussi T; Department of Life Science, UPMC University, Sorbonne Université, Paris, France.; Centre de Recherche des Cordeliers, INSERM, Paris, France.; Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden., Kurzrock R; Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Dec; Vol. 19 (12), pp. 2612-2620. Date of Electronic Publication: 2020 Sep 30.